Indeed, Gatza et al. have described that the injection of ECP-treated splenocytes from mice developing GvHD (i.e., containing allogeneic T cells) triggers IL-10-producing regulatory T cells (Tregs) able to reverse experimental GvHD (10). This evidence concerns the gene IL10 and graft versus host disease.